Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart

Faculty Medicine Year: 2007
Type of Publication: ZU Hosted Pages:
Authors:
Journal: European Heart Journal Oxford academic Volume: 2
Keywords : Glucose lowering treatment , patients with coronary    
Abstract:
Abstract Aims Glucose lowering (GL) therapy in patients with diabetes mellitus (DM) and coronary artery disease (CAD) is prognostically important. This report from the Euro Heart Survey on Diabetes and the Heart describes present practice in relation to 1 year prognosis. Methods and results The survey enrolled 4676 patients with CAD from 110 centres out of whom 1425 had known and 452 newly detected DM. The impact of different GL modalities on cardiovascular events (CVE: death, myocardial infarction, or stroke) was followed. Insulin treated patients with known DM (n = 378) had an adjusted 1 year hazard ratio (HR) for mortality of 2.23 (95% CI 1.24–4.03; P = 0.006) and for CVE of 1.27 (95% CI 0.85–1.87; P = 0.230) compared with those on oral GL drugs (n = 675). Of patients with newly detected DM 77 (17%) were started on GL drugs. None of them died compared with 25 (P = 0.002) among those without such treatment and their 1 year CVE HR was 0.22 (95% CI 0.05–0.97; P = 0.041) compared with untreated subjects. Conclusion Insulin therapy may relate to a more serious prognosis in CAD-patients with DM. There was a pronounced decrease in cardiovascular events in patients with newly detected DM prescribed GL drugs compared with those not receiving such treatment.
   
     
 
       

Author Related Publications

  • Aly Mohamed Abdelrahman Saad, "The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe The Euro Heart Survey on diabetes and the heart", Elsevier, 2004 More
  • Aly Mohamed Abdelrahman Saad, "Treatment and Health Status in Patients with Proven Coronary Artery Disease, but Ineligible for Revascularization. A Report from the Euro Heart Survey on Revascularization", Sage, 2006 More
  • Aly Mohamed Abdelrahman Saad, "Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization: Results from the Euro Heart Survey on coronary revascularization", Sage, 2006 More
  • Aly Mohamed Abdelrahman Saad, "A 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from The Euro Heart Survey on Coronary Revascularization", Oxford University Press, 2006 More
  • Aly Mohamed Abdelrahman Saad, "Atrial fibrillation management: a prospective survey in ESC Member Countries", Oxford University Press, 2005 More

Department Related Publications

  • Ahmed Shafea Mahmoud Morsy, "تاثير توسيع الصمام الميترالي بالقسطرة البالةنية على ارتجاع الوظيفي للصمام ثلاثى الشرفات وارتفاع ضغط الشريان الرئوى", مجلة جامعة الزقازيق الطبية, 2000 More
  • Mohamed Ibrahim Mustafa AlAwadi, "القيمة التنبؤية لقصور الشريان التاجى الخفى فى مرضى احتشاء عضلة القلب الحاد اثناء فترة الاقامة بالمستشفى", مجلة جامعة الزقازيق الطبية, 2000 More
  • Mohamed Ibrahim Mustafa AlAwadi, "ضغوط الاكسدة ونشاط مضادات الاكسدة فى مرضى البول السكرى الغير معتمد على الانسولين ويعانون من متلازمة الشريان التاجى الغير مستقرة", مجلة جامعة الزقازيق الطبية, 1999 More
  • Salwa Mohamed Mohamed Elsayed Ghoniem, "قصور الشريان التاجى والمختفى فى مرضى السكر الغير معتمدين على الانسولين فى وجود او عدم وجود زلال البول السكرى", مجلة القلب المصرية, 2000 More
  • Tarek Abdelmoniem Abdelaziz, "Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats", Springer, 2012 More
Tweet